Skip to main content

previous disabled Page of 8
and
  1. Article

    Open Access

    Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits

    Jiaojiao Hao, Wenhua Fan, Yizhuo Li in Journal of Experimental & Clinical Cancer … (2024)

  2. Article

    Retraction Note: Curcumin amends Ca2 + dysregulation in microglia by suppressing the activation of P2 × 7 receptor

    Zhen Wang, Weihua Ren, Fucheng Zhao, Yanru Han in Molecular and Cellular Biochemistry (2024)

  3. No Access

    Article

    Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk

    Insight into associations between the gut microbiome with metabolism and aging is crucial for tailoring interventions to promote healthy longevity. In a discovery cohort of 10,207 individuals aged 40–93 years,...

    Tiange Wang, Zhun Shi, Huahui Ren, Min Xu, Jieli Lu, Fangming Yang in Nature Medicine (2024)

  4. No Access

    Article

    Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial

    Poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors as maintenance therapy after first-line chemotherapy have improved progression-free survival in women with advanced ovarian cancer; however, not ...

    **aohua Wu, Jihong Liu, **g Wang, Li Wang, Zhongqiu Lin, **aobin Wang in Nature Medicine (2024)

  5. Article

    Open Access

    Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22–09

    Next-generation sequencing (NGS) has been introduced to many Korean institutions to support molecular diagnostics in cancer since 2017, when it became eligible for reimbursement by the National Health Insuranc...

    Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, Sook Ryun Park, Shinkyo Yoon in BMC Cancer (2024)

  6. Article

    Open Access

    PBX/Knotted 1 homeobox-2 (PKNOX2) is a novel regulator of myocardial fibrosis

    Much effort has been made to uncover the cellular heterogeneities of human hearts by single-nucleus RNA sequencing. However, the cardiac transcriptional regulation networks have not been systematically describ...

    Liang Chen, Haotong Li, **aorui Liu in Signal Transduction and Targeted Therapy (2024)

  7. No Access

    Article

    Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis

    As a vital component of the hepatitis B virus (HBV) nucleocapsid, HBV core protein (HBC) contributes to hepatocarcinogenesis. Here, we aimed to assess the effects of RANGAP1 and KDM2A on tumorigenesis induced ...

    Hong-Juan You, Li-Hong Ma, **ng Wang, Yu-**n Wang, Huan-Yang Zhang in Cellular Oncology (2024)

  8. Article

    Open Access

    A single-cell atlas enables map** of homeostatic cellular shifts in the adult human breast

    Here we use single-cell RNA sequencing to compile a human breast cell atlas assembled from 55 donors that had undergone reduction mammoplasties or risk reduction mastectomies. From more than 800,000 cells we i...

    Austin D. Reed, Sara Pensa, Adi Steif, Jack Stenning, Daniel J. Kunz in Nature Genetics (2024)

  9. Article

    Open Access

    Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis

    The prognostic significance of tumor burden score (TBS) in relation to carcinoembryonic antigen (CEA) has not been investigated among patients undergoing hepatectomy for intrahepatic cholangiocarcinoma (ICC). ...

    Jun Fu, Lifang Zheng, Shicuan Tang, Kongying Lin, Shuguo Zheng, **nyu Bi in BMC Cancer (2024)

  10. Article

    Open Access

    Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis

    Despite the improvements in clinical outcomes for DLBCL, a significant proportion of patients still face challenges with refractory/relapsed (R/R) disease after receiving first-line R-CHOP treatment. To furthe...

    Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, **anhuo Wang in Leukemia (2024)

  11. Article

    Open Access

    Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy

    The cGAS-STING signaling pathway has emerged as a critical mediator of innate immune responses, playing a crucial role in improving antitumor immunity through immune effector responses. Targeting the cGAS-STIN...

    ** Chen, Zhijie Xu, Tongfei Li, Abhimanyu Thakur, Yu Wen, Kui Zhang in Biomarker Research (2024)

  12. Article

    Open Access

    A compendium of genetic regulatory effects across pig tissues

    The Farm Animal Genotype-Tissue Expression (FarmGTEx) project has been established to develop a public resource of genetic regulatory variants in livestock, which is essential for linking genetic polymorphisms...

    **yan Teng, Yahui Gao, Hongwei Yin, Zhonghao Bai, Shuli Liu in Nature Genetics (2024)

  13. Article

    Open Access

    Clinical application of 192Ir High-Dose-Rate brachytherapy in metastatic lymph nodes of the neck

    The objective of this study was to investigate the safety and effectiveness of high-dose-rate brachytherapy as a treatment modality for recurrent or residual neck metastatic lymph nodes following external radi...

    Hongling Lu, Yunchuan Sun, Yan Gao, Li **ao, Jianxi Zhou, **aoming Yin in Discover Oncology (2023)

  14. Article

    Open Access

    RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer

    The aim of this study was to explore the associations of RIPK1 polymorphisms, plasma levels and mRNA expression with susceptibility to epithelial ovarian cancer (EOC) and clinical outcome.

    Xuedong Wang, Kui Deng, **g Tao, Juan Zou, Yiting Du, Li Dai in Cancer Cell International (2023)

  15. Article

    Open Access

    Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer’s disease

    Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the predominant impairment of neurons in the hippocampus and the formation of amyloid plaques, hyperphosphorylated tau protein, and neu...

    Ashok Iyaswamy, Abhimanyu Thakur, **n-Jie Guan in Signal Transduction and Targeted Therapy (2023)

  16. Article

    Open Access

    Publisher Correction: Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

    Jun Yin, **gnan Yuan, Yun** Li, Yong Fang, Ruoxi Wang, Heng Jiao in Nature Medicine (2023)

  17. No Access

    Article

    Apatinib combined with olaparib induces ferroptosis via a p53-dependent manner in ovarian cancer

    PARP inhibitors combined with antiangiogenic drugs have been reported to improve outcomes in BRCA wild-type ovarian cancer patients, the mechanism of the combination is unclear. In this study, we explored the ...

    Wang Yue, Gu Yupeng, Cao Jun, Jiang Kui in Journal of Cancer Research and Clinical Oncology (2023)

  18. Article

    Open Access

    Using deep learning to predict survival outcome in non-surgical cervical cancer patients based on pathological images

    We analyzed clinical features and the representative HE-stained pathologic images to predict 5-year overall survival via the deep-learning approach in cervical cancer patients in order to assist oncologists in...

    Kun Zhang, Kui Sun, Caiyi Zhang, Kang Ren in Journal of Cancer Research and Clinical On… (2023)

  19. Article

    Open Access

    Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial

    Overall survival (OS) benefits of neoadjuvant immunotherapy remain elusive in locally advanced esophageal squamous cell carcinomas (ESCC). Here, we reported the results of a phase 1b trial of neoadjuvant PD-L1...

    Jun Yin, **gnan Yuan, Yun** Li, Yong Fang, Ruoxi Wang, Heng Jiao in Nature Medicine (2023)

  20. No Access

    Article

    Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway

    The aberrantly up-regulated CDK9 can be targeted for cancer therapy. The CDK inhibitor dinaciclib (Dina) has been found to drastically sensitizes cancer response to TRAIL-expressing extracellular vesicle (EV-T...

    Qian Yuan, Kui Su, Shuyi Li, **nyi Long, Lang Liu, Jianwu Sun, **n Yuan in Apoptosis (2023)

previous disabled Page of 8